NeuroSearch announced a three year collaboration with Eli Lilly & Co to discover and develop CNS therapeutics through the modulation of ion channels. The deal builds on the know-how and intellectual property from both companies and is an example of how Lilly is looking at external collaborations to fill its pipeline.